Loading...
INDEX: NASDAQ
SYMBOL: APRI
NAME: Apricus Biosciences Inc
UPVOTES: 71
DOWNVOTES: 72


Description

Apricus Biosciences, Inc. is a pharmaceutical company, which develops pharmaceutical products. The Company primarily focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. The Company's drug delivery technology is a permeation enhancer called NexACT. The Company has over two product candidates in Phase II development, fispemifene for the treatment of symptomatic male secondary hypogonadism and RayVa for the treatment of Raynaud's phenomenon, secondary to scleroderma. The Company has a commercial product, Vitaros for the treatment of erectile dysfunction (ED), which is in development in the United States, approved in Canada and marketed throughout Europe.

Read Full Descript at Reuters

APRI Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
ACB30
ARCB20
AUMN10
AMER21
ALQA10
ADMS10
ACET11
APAFF01
AREX01
AIM01
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661
Stock SymbolUp VotesDown VotesVote
ALIM52
AGNC63
ACB52
ARCB63
TKSTF31
AMDA42
AXS53
ATTBF42
AMER53
ACAD42
Stock SymbolUp VotesDown VotesVote
SDVI189
AGNC126
ARCB1410
AAPL128
ALIM85
ACAD85
A96
QSEP63
AXS108
IPG31
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661

Last 10 Stocks Voted On

Stock SymbolActionVote
ACETUPVOTE
AMERDOWNVOTE
AMERUPVOTE
ACETDOWNVOTE
AGMDOWNVOTE
AETDOWNVOTE
ARCBUPVOTE
ALQAUPVOTE
ARCBUPVOTE
ACBUPVOTE